PNPLA3 and hepatocellular carcinoma: The PNPLA3 variant predicts HCC development in European patients with NAFLD21, suggesting that genetic risk factors may prove helpful to select high-risk individuals for screening21–23, but has a low specificity to be used as single prognostic biomarker24.